Institutional investors purchased a net $864.8 thousand shares of INSM during the quarter ended December 2012 and now own 38.85% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIMED ADVISORS LLC Bought 774.0 Thousand shares of Insmed Inc